26 January 2017
Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum
London, 25 January 2017, Consilium Strategic Communications, a global leader in strategic healthcare communications, today joins co-sponsors J.P. Morgan, Manches, Numis, Penningtons, PwC, partners BioIndustry Association (BIA) and One Nucleus, and hosts London Stock Exchange at the third Future of Healthcare Investor Forum.
Key sector statistics presented include:
- Sector value on London Stock Exchange nears £400 billion market cap, £40 billion ahead of 2015, with US healthcare and life science companies continuing to see London as natural home
- £1.96 billion raised in life science IPOs and further offerings in 2016
- Over three years the FTSE Healthcare AIM and FTSE Healthcare All Share Indexes have outperformed wider indexes to end 2016 +48% and +16% respectively, compared to +7% for the FTSE All Share Index
- UK at the forefront of life science innovation, fundraising and investment
The full London Stock Exchange press release related to the event is here: [LINK]
For more information, please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Chris Gardner
Tel: +44(0)20 3709 5700
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in strategic healthcare communications advisory with offices in London and New York. Consilium's highly-skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300 and FTSE250, through to discrete specialist reputation management projects.